DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
DRNA
Delisted
DRNA was delisted on the 27th of December, 2021.
144 hedge funds and large institutions have $1.13B invested in Dicerna Pharmaceuticals, Inc. in 2020 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 52 increasing their positions, 53 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
62% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 37
75% less call options, than puts
Call options by funds: $292K | Put options by funds: $1.15M
Holders
144
Holding in Top 10
5
Calls
$292K
Puts
$1.15M
Top Buyers
| 1 | +$66.2M | |
| 2 | +$20M | |
| 3 | +$11.5M | |
| 4 |
ACM
Aquilo Capital Management
San Francisco,
California
|
+$11.4M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$8.15M |
Top Sellers
| 1 | -$13.4M | |
| 2 | -$12M | |
| 3 | -$11M | |
| 4 |
BM
Bridger Management
New York
|
-$5.55M |
| 5 |
EC
EcoR1 Capital
San Francisco,
California
|
-$5.17M |